Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors

Conditions

• Advanced Malignant Solid Tumor

Interventions

• BIOLOGICAL: Neoantigen Reactive T Cells(NRTs)
• BIOLOGICAL: SHR-1210
• DRUG: Fludarabine
• DRUG: Cyclophosphamide
• BIOLOGICAL: Interleukin-2

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School